• Clinical efficiency of correction of the state of vaginal microbiota in women with disorders of reproductive health and the postpartum purulent-septic complications in anamnesis

Clinical efficiency of correction of the state of vaginal microbiota in women with disorders of reproductive health and the postpartum purulent-septic complications in anamnesis

HEALTH OF WOMAN. 2018.5(131):40–43; doi 10.15574/HW.2018.131.40

Pyrohova V., Feita Yu., Shurpyak S.
Lviv national medical University named Danylo Galitsky

Vaginal flora plays an important role in the functioning of the reproductive system.

The objective: was to evaluate the efficacy and tolerability of vaginal suppositories of Florica (producer «Lekhim-Kharkiv») in maintaining a normal balance of vaginal microbiota to prevent recurrences of bacterial vaginosis, aerobic and mixed vaginal dysbiosis.

Materials and methods. 45 women of reproductive age (from 22 to 35 years) with burdened reproductive (miscarriage, premature birth) and obstetric (postpartum purulent-septic diseases) history were under observation.

Results. Application to maintain a normal balance of the vaginal microbiota and prevent the development of dysbiotic processes after the completion of the main course of treatment of BV and aerobic vaginitis of vaginal suppositories Florica, which contain a specially treated mass of live lactic bacteria in optimal quantities to maintain a healthy balance of the microflora of the female sexual sphere (5107 Lactobacillus acidophilus and Bifidobacterium) allows to reduce the frequency of recurrence of BV in 2.9 times.

Conclusion. The frequency of recurrence of BV in routine clinical practice is 35.0% during 6 months of observation, which indicates the need to develop effective measures to prevent the recurrence of vaginal dysbiotic processes.

Key words: vaginal microbiota, vaginal dysbiosis, bacterial vaginosis, aerobic vaginitis, topical therapy.

REFERENCES

1. Belkina OV, Tsynko NI, Lomakina OI, Oleshko VF. 2010. Dysbiotychni porushennia pikhvy na tli nevynoshuvannia vahitnosti. Perspektyvy medytsyny ta biolohii 2(1, dodatok):48–49.

2. Hnatko OP. 2010. Bakterialnyi vahinoz u vahitnykh. Simeina medytsyna 2:32–35.

3. Grischenko OV, Lahno IV, Dudko VL. 2010. Vyibor metoda terapii i lekarstvennoy formyi preparata dlya lecheniya patsientok s vaginalnyim disbiozom. Zdorove zhenschiny 4(50):86–88.

4. Dobrohotova YuE. 2013. Nevinashivanie beremennosti: infektsionnyie faktoryi. Med. aspektyi zdorovya zhenschiny 5(69):32–37.

5. Zaharova TV, Volkov VG. 2010. Korektsiya narusheniiy vaginalnoy mikrofloryi pri bakterialnyih vaginozah, nespetsificheskih vaginitah. Akusherstvo ta ginekologiya 5:102–106.

6. Kira EF. 2012. Bakterialnyiy vaginoz. Meditsinskoe informatsionnoe agentstvo:472.

7. Voroshilina ES. 2011. Sovremennyie vozmozhnosti diagnostiki bakterialnogo vaginoza: issledovanie kolichestvennogo i kachestvennogo sostava slozhnyih mikrobnyih soobschestv. Mikrobiologiya 13:70–74.

8. Radzinskiy VE. 2011. Akusherskaya agressiya. M, Izd-vo zhurnala Status Praesens:688.

9. Tirskaya YuI, Barinov SV, Dolgih TI i dr. 2013. Profilaktika razvitiya poslerodovogo endometrita u rodilnits gruppyi infektsionnogo riska. Akusherstvo i ginekologiya 3:75–79.

10. Amsel R. 1983. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74(1):14–22. https://doi.org/10.1016/0002-9343(83)91112-9

11. Larsson PG. 2015. Bacterial vaginosis. Transmission, role in genital tract infection and pregnancy outcome: an enigma. APMIS. 113(4):233–245. https://doi.org/10.1111/j.1600-0463.2005.apm_01.x

12. Nappi RE, Kokot-Kierepa M. 2012. Vaginal Health: Insights, views and Attitudes (viva) results from an international survey. Climacteric. 15:36–44. https://doi.org/10.3109/13697137.2011.647840; PMid:22168244

13. Sharma H, Tal R, Clark NA, Segars JH. 2014. Microbiota and pelviс inflammatory disease. Semin. Reprod. Med. 32(1):48–49.